Evidence map›Paper›PMID 20043826›Full record

ArticleBMC microbiology2009

The chlamydial functional homolog of KsgA confers kasugamycin sensitivity to Chlamydia trachomatis and impacts bacterial fitness.

Rachel Binet, Anthony T Maurelli

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Microorganisms · 2023
    Review
  4. Microorganisms · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Antibiotic resistance in Chlamydiae.Future microbiology · 2010
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Rachel BinetDepartment of Microbiology and Immunology, F, Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA. rbinet@usuhs.mil
Anthony T Maurelli
Uniformed Services University of the Health Sciences · USUnited States Food and Drug Administration · US

Funding

MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITYR01AI044033 · NIAID · UNIVERSITY OF FLORIDA · PI MAURELLI, ANTHONY T · 1999 to 2016
$3.9M
Molecular Genetic Analysis of Chlamydia PathogenicityR21AI044033 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MAURELLI, ANTHONY T · 2004 to 2004
$301k
NIAID NIH HHS AI44033
6 · The paper itself

Abstract

backgroundrRNA adenine dimethyltransferases, represented by the Escherichia coli KsgA protein, are highly conserved phylogenetically and are generally not essential for growth. They are responsible for the post-transcriptional transfer of two methyl groups to two universally conserved adenosines located near the 3'end of the small subunit rRNA and participate in ribosome maturation. All sequenced genomes of Chlamydia reveal a ksgA homolog in each species, including C. trachomatis. Yet absence of a S-adenosyl-methionine synthetase in Chlamydia, the conserved enzyme involved in the synthesis of the methyl donor S-adenosyl-L-methionine, raises a doubt concerning the activity of the KsgA homolog in these organisms.

resultsLack of the dimethylated adenosines following ksgA inactivation confers resistance to kasugamycin (KSM) in E. coli. Expression of the C. trachomatis L2 KsgA ortholog restored KSM sensitivity to the E. coli ksgA mutant, suggesting that the chlamydial KsgA homolog has specific rRNA dimethylase activity. C. trachomatis growth was sensitive to KSM and we were able to isolate a KSM resistant mutant of C. trachomatis containing a frameshift mutation in ksgA, which led to the formation of a shorter protein with no activity. Growth of the C. trachomatis ksgA mutant was negatively affected in cell culture highlighting the importance of the methylase in the development of these obligate intracellular and as yet genetically intractable pathogens.

conclusionThe presence of a functional rRNA dimethylase enzyme belonging to the KsgA family in Chlamydia presents an excellent chemotherapeutic target with real potential. It also confirms the existence of S-adenosyl-methionine--dependent methylation reactions in Chlamydia raising the question of how these organisms acquire this cofactor.

Indexed as

Amino Acid SequenceAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsChlamydia trachomatisDNA, BacterialDrug Resistance, BacterialEscherichia coliFrameshift MutationGenetic Complementation TestMethyltransferasesMolecular Sequence DataPhylogenySequence Analysis, DNA16S rRNA (adenine(1518)-N(6)-adenine(1519)-N(6))-dimethyltransferaseAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsDNA, BacterialkasugamycinMethyltransferases

Identifiers

PMID20043826
PMCPMC2807437
OpenAlexW2003182910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.